Humana Inc. (NYSE:HUM) Shares Sold by Metis Global Partners LLC

Metis Global Partners LLC trimmed its position in shares of Humana Inc. (NYSE:HUM) by 0.9% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 5,002 shares of the insurance provider’s stock after selling 43 shares during the period. Metis Global Partners LLC’s holdings in Humana were worth $1,584,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in the company. Mendota Financial Group LLC increased its stake in Humana by 9.2% during the second quarter. Mendota Financial Group LLC now owns 319 shares of the insurance provider’s stock worth $119,000 after acquiring an additional 27 shares during the last quarter. Capital Advisors Ltd. LLC increased its position in Humana by 17.0% during the 2nd quarter. Capital Advisors Ltd. LLC now owns 213 shares of the insurance provider’s stock worth $80,000 after purchasing an additional 31 shares in the last quarter. CarsonAllaria Wealth Management Ltd. raised its holdings in Humana by 111.4% in the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after buying an additional 39 shares during the period. Harbour Investments Inc. lifted its position in Humana by 10.5% during the second quarter. Harbour Investments Inc. now owns 432 shares of the insurance provider’s stock valued at $161,000 after buying an additional 41 shares in the last quarter. Finally, Baader Bank Aktiengesellschaft grew its stake in Humana by 1.0% during the second quarter. Baader Bank Aktiengesellschaft now owns 4,421 shares of the insurance provider’s stock worth $1,649,000 after buying an additional 42 shares during the period. 92.38% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

HUM has been the topic of several recent research reports. Barclays lifted their target price on shares of Humana from $250.00 to $253.00 and gave the company an “equal weight” rating in a report on Thursday, October 31st. Wells Fargo & Company reduced their price objective on Humana from $387.00 to $290.00 and set an “overweight” rating on the stock in a research note on Monday, November 4th. KeyCorp initiated coverage on Humana in a research note on Friday, October 11th. They issued a “sector weight” rating for the company. JPMorgan Chase & Co. boosted their price target on Humana from $332.00 to $396.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 21st. Finally, Sanford C. Bernstein upgraded shares of Humana from a “market perform” rating to an “outperform” rating and set a $308.00 price objective on the stock in a research note on Tuesday, October 8th. Twenty investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $315.86.

Humana Stock Down 2.6 %

HUM stock opened at $275.67 on Friday. The firm has a fifty day moving average price of $281.36 and a two-hundred day moving average price of $331.61. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $527.18. The firm has a market cap of $33.19 billion, a price-to-earnings ratio of 24.42, a PEG ratio of 2.29 and a beta of 0.52.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, beating analysts’ consensus estimates of $3.48 by $0.68. Humana had a net margin of 1.18% and a return on equity of 13.20%. The business had revenue of $29.30 billion during the quarter, compared to the consensus estimate of $28.66 billion. Research analysts predict that Humana Inc. will post 15.83 EPS for the current year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.28%. The ex-dividend date is Tuesday, December 31st. Humana’s dividend payout ratio (DPR) is 31.36%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.